Hyperemesis gravidarum (HG) is driven primarily by a protein called GDF15 that surges during early pregnancy and activates nausea receptors in the brainstem. But it’s not a single-cause condition. A combination of hormonal shifts, genetic predisposition, and individual sensitivity determines who develops severe pregnancy vomiting and who experiences only mild nausea. Symptoms typically begin around 6 weeks of gestation, peak between 9 and 16 weeks, and resolve by weeks 16 to 20, though about 20% of cases persist throughout the entire pregnancy.
The GDF15 Protein and Brainstem Sensitivity
The most significant breakthrough in understanding HG came from research into a stress-response protein called GDF15. Outside of pregnancy, your body produces small amounts of GDF15 in response to various types of cellular stress. Its receptor sits exclusively in the hindbrain, and when GDF15 binds to it, the result is nausea, vomiting, and food aversion. Starting in early pregnancy, the placenta and fetus begin producing large amounts of GDF15, flooding the bloodstream with levels far higher than the body is used to.
Here’s the key insight: it’s not just how much GDF15 your body encounters during pregnancy that matters. It’s how accustomed your body was to GDF15 before you became pregnant. Research published in Nature demonstrated that the nausea response to GDF15 is subject to desensitization. Women who naturally had higher baseline levels of GDF15 before pregnancy appear to tolerate the surge better, because their brainstem receptors are already somewhat adapted. Women with low pre-pregnancy GDF15 levels experience the fetal surge as a dramatic spike, triggering intense nausea and vomiting. This explains why some women sail through pregnancy with mild queasiness while others are hospitalized with relentless vomiting, even when their pregnancies are otherwise identical.
The Role of hCG
Human chorionic gonadotropin (hCG), the hormone that makes a pregnancy test turn positive, has long been considered a central factor in pregnancy nausea. The timing is hard to ignore: hCG levels climb rapidly in the first trimester, peaking around 9 to 16 weeks of gestation, which closely mirrors when HG symptoms are at their worst. One clinical study found a strong positive correlation (r = 0.70) between maternal hCG levels and nausea severity scores, reinforcing the idea that hCG is a major player.
Women carrying twins produce higher average hCG concentrations (219 IU/L versus 130 IU/L in singleton pregnancies) and develop HG at nearly double the rate: 2.7% compared to 1.4%. This dose-response pattern, where more hCG means more vomiting, is one of the strongest pieces of evidence linking the hormone to severe nausea. However, hCG likely doesn’t act alone. Researchers believe it works alongside GDF15 and other hormonal changes to push the nausea system past its threshold.
How hCG Disrupts Thyroid Function
One of the lesser-known effects of high hCG is its ability to stimulate the thyroid gland. The hCG molecule shares a structural subunit with thyroid-stimulating hormone (TSH), which means it can bind to TSH receptors through a process called molecular mimicry. In women with very high hCG levels, this cross-reactivity can trigger transient hyperthyroidism, a temporary state of thyroid overactivity that adds symptoms like a racing heart, tremors, and heat intolerance on top of the nausea. This thyroid disruption is usually self-limiting and resolves as hCG levels decline in the second trimester, but in rare cases it can escalate.
Genetic Predisposition
HG runs in families, and genome-wide studies have identified specific genes that increase susceptibility. The two most strongly associated are GDF15 and IGFBP7, both of which are involved in placental development, appetite regulation, and the body’s wasting response (cachexia). Variations in these genes likely influence how much GDF15 the placenta produces, how sensitive the brainstem receptor is, or how effectively the body manages appetite signals during early pregnancy.
The genetic component also shows up clearly in recurrence data. Among women who had HG in one pregnancy, roughly 89% experienced it again in subsequent pregnancies. That near-certainty of recurrence points to a strong biological predisposition rather than random chance or lifestyle factors.
Risk Factors That Increase Your Odds
Beyond genetics, several factors raise the likelihood of developing HG:
- Multiple pregnancies. Carrying twins or triplets means higher hCG and GDF15 production, nearly doubling the risk compared to a singleton pregnancy.
- Previous HG. A history of HG in an earlier pregnancy is the single strongest predictor, with recurrence rates near 89%.
- Family history. Having a mother or sister who experienced HG increases your risk, consistent with the genetic associations described above.
What Happens Inside the Body During Severe HG
HG is clinically defined as persistent nausea and vomiting severe enough to cause weight loss of at least 5% below pre-pregnancy weight. At that level of vomiting, the body can’t absorb enough nutrients or fluids, leading to dehydration, electrolyte imbalances, and the production of ketones as the body starts breaking down fat for energy.
One of the most serious nutritional consequences is thiamine (vitamin B1) depletion. Thiamine is essential for energy metabolism in the brain, and the brain burns through its thiamine stores quickly. When vomiting prevents adequate intake for weeks, thiamine levels can drop low enough to cause a neurological emergency called Wernicke encephalopathy. This condition damages specific brain structures responsible for consciousness, eye movement, and balance, leading to confusion, vision problems, and difficulty walking. If thiamine isn’t replaced promptly, the damage can become permanent, progressing to lasting memory impairment. This complication is rare but well-documented in severe HG cases, which is why nutritional support is a critical part of treatment.
Why It’s Not “Just Morning Sickness”
About 70 to 80% of pregnant women experience some nausea in the first trimester. HG sits at the extreme end of that spectrum, affecting roughly 1 to 3% of pregnancies. The difference isn’t just severity. The underlying biology suggests that women with HG have a fundamentally different physiological response to pregnancy hormones, shaped by their pre-pregnancy GDF15 baseline, their genetic makeup, and the volume of hormones their particular pregnancy produces. Ordinary morning sickness involves mild nausea that responds to dietary changes and doesn’t cause significant weight loss. HG involves relentless vomiting that leads to dehydration, malnutrition, and often hospitalization.
Understanding HG as a biological condition with identifiable molecular drivers, rather than a psychological or behavioral problem, has been one of the most important shifts in how the condition is viewed. The discovery of the GDF15 pathway in particular has opened the door to targeted approaches that address the root cause rather than just managing symptoms.